Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial

Table 1 Demographics and operative characteristics of patients who received either immunonutrition or standard care preoperatively

	Immunonutrition	Standard care
n	17	15
Male/Female	11/6	10/5
Age (yr)	61 (28 – 76)	63 (31–79)
SGA grade (A/B/C)	15/1/1	13/2/0
Indication for surgery
Metastatic disease	15	13
Hepatocellular carcinoma	2	1
Granulomatous liver disease	0	1
Hepatectomy
Major resection ( ≥ 3 segments)	14	10
Minor resection ( < 3 segments)	3	5
ASA grade (I/II/III)	1/9/6	0/8/6
Tissue removed (g)	815 ± 123	610 ± 94
Duration of surgery (min)	173 (104-337)	155 (128-246)

Data are number of patients, mean ± SE or median (range). SGA: Subjective global assessment; ASA: American Society of Anaesthesiologists physical status classification.